Scan to Download
One power score. Smarter investment decisions
CERo Therapeutics Holdings Inc
CERO5.400USD
-0.030-0.55%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
USD0.000After-hours (ET)
6.45MMarket Cap
LossP/E TTM
CERo Therapeutics Holdings Inc
5.400
-0.030-0.55%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
Operating expenses
-8.24%4.72M
8.75%4.95M
86.90%2.10M
186.68%4.40M
113.29%5.15M
86.69%4.55M
--1.12M
--1.54M
--2.41M
--2.44M
R&D expenses
1.46%2.75M
74.31%2.91M
-9.34%922.98K
38.88%1.77M
127.51%2.71M
-7.32%1.67M
--1.02M
--1.28M
--1.19M
--1.80M
Depreciation, depletion, and amortization
-33.25%76.29K
-32.87%76.29K
-15.87%96.38K
-1.33%113.86K
-0.94%114.30K
-1.51%113.64K
--114.56K
--115.39K
--115.39K
--115.39K
Operating profit
8.24%-4.72M
-8.75%-4.95M
-86.90%-2.10M
-186.68%-4.40M
-113.29%-5.15M
-86.69%-4.55M
---1.12M
---1.54M
---2.41M
---2.44M
Net non-operating interest income (expenses)
Non-operating interest income
--13.78K
--850.00
-81.72%48.84K
2714.01%4.42K
----
----
--267.22K
--157.00
--59.42K
--16.00
Special income (expenses)
----
----
102.43%10.00K
-8.64%170.00K
1007.62%2.90M
--2.26M
---411.23K
--186.07K
--261.82K
--0.00
Other non-operating income (expenses)
-285.58%-707.30K
---156.25K
--2.71M
---147.00
---183.44K
----
----
--0.00
--0.00
----
Income before tax
-121.24%-5.42M
-122.03%-5.11M
153.11%671.89K
-213.33%-4.23M
-17.02%-2.45M
5.69%-2.30M
---1.27M
---1.35M
---2.09M
---2.44M
Income after tax
-121.24%-5.42M
-122.03%-5.11M
153.11%671.89K
-213.33%-4.23M
-17.02%-2.45M
5.69%-2.30M
---1.27M
---1.35M
---2.09M
---2.44M
Net income from continuous operations
-121.24%-5.42M
-122.03%-5.11M
153.11%671.89K
-213.33%-4.23M
-17.02%-2.45M
5.69%-2.30M
---1.27M
---1.35M
---2.09M
---2.44M
Net income attributable to controlling interests
-1129.97%-30.12M
-137.17%-5.45M
-67.01%-2.11M
-213.33%-4.23M
-17.02%-2.45M
5.69%-2.30M
---1.27M
---1.35M
---2.09M
---2.44M
Preferred share dividend
--24.70M
--348.23K
--2.78M
----
----
----
----
----
----
----
Net income attributable to common shareholders
-1129.97%-30.12M
-137.17%-5.45M
-67.01%-2.11M
-213.33%-4.23M
-17.02%-2.45M
5.69%-2.30M
---1.27M
---1.35M
---2.09M
---2.44M
Basic earnings per share
-473.01%-61.71
-103.52%-31.82
57.03%-3.65
68.34%-2.87
23.28%-10.77
4.40%-15.64
---8.49
---9.05
---14.04
---16.36
Diluted earnings per share
-473.01%-61.71
-103.52%-31.82
57.03%-3.65
68.34%-2.87
23.28%-10.77
4.40%-15.64
---8.49
---9.05
---14.04
---16.36
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
